Overview
Portfolio
More
Martletcap
Cambridge, United Kingdom
Provides patient capital and hands‑on support to early‑stage deep‑tech and life‑sciences B2B startups, focusing on transformative technologies.
Portfolio
43+
Employees
10+
Founded
N/A
AUM
N/A
Investment focus
Stages
No stages listed
Industries
No industries listedGeographic scope
United Kingdom
Sources
Martletcap
Provides patient capital and hands‑on support to early‑stage deep‑tech and life‑sciences B2B startups, focusing on transformative technologies.
Portfolio
43+
Employees
10+
Founded
N/A
AUM
N/A
Stages
No stages listed
Industries
No industries listedGeographic scope
United Kingdom
Sources
Showing 24 of 27 matched portfolio companies
AIVIVO LTD develops artificial intelligence systems that generate multi-modal omics data to create OrganoMaps, which connect disease biology with treatment interventions at the organ level. This approach enables the development of targeted medicines for patients by providing insights into organ-specific disease mechanisms.
Funding: $3.6M
Rough estimate of the amount of funding raised
Funding: $3.6M
Rough estimate of the amount of funding raised
AllFocal Optics develops nanophotonic solutions that enhance display technology by providing natural visual clarity and comfort, particularly for users with vision impairments such as myopia and astigmatism. The company's technology, rooted in research from Cambridge University, ensures compatibility and scalability for next-generation visual experiences.
Funding: $9.1M
Rough estimate of the amount of funding raised
Funding: $9.1M
Rough estimate of the amount of funding raised
Cambridge GaN Devices develops enhancement-mode GaN transistors that operate with standard silicon gate drivers, eliminating the need for costly external driving interfaces. Their technology addresses the inefficiencies of traditional silicon devices by enabling higher switching frequencies and reducing energy losses by up to 50%, resulting in smaller and more efficient consumer electronics.
Funding: $60.0M
Rough estimate of the amount of funding raised
Funding: $60.0M
Rough estimate of the amount of funding raised
Closed Loop Medicine develops personalized digital healthcare solutions that integrate dose-optimized drug therapy with digital therapeutics to enhance treatment adherence and patient outcomes. The platform addresses the inefficiencies of traditional healthcare delivery, which often leads to suboptimal management of chronic conditions and increased costs for payors.
Funding: $28.6M
Rough estimate of the amount of funding raised
Funding: $28.6M
Rough estimate of the amount of funding raised
Converge utilizes real-time concrete sensors and AI-driven analytics to monitor concrete strength and temperature, enabling contractors to optimize construction timelines and resource allocation. This technology addresses inefficiencies in concrete management, reducing project durations by up to 30% while minimizing waste and carbon emissions.
Funding: $22.0M
Rough estimate of the amount of funding raised
Funding: $22.0M
Rough estimate of the amount of funding raised
Dogtooth develops intelligent robots for soft fruit harvesting, utilizing a patented inspection system that employs 360-degree imaging to assess berry mass, ripeness, and defects. By providing real-time yield insights and enabling night picking, Dogtooth addresses labor shortages and enhances efficiency in fruit production for growers.
Funding: $5.1M
Rough estimate of the amount of funding raised
Funding: $5.1M
Rough estimate of the amount of funding raised
Echion Technologies produces XNO® niobium-based anode materials for lithium-ion batteries, enabling fast charging in under 10 minutes and a cycle life exceeding 10,000 cycles. This technology addresses the need for high energy density and safety in heavy-duty electric vehicles and industrial applications, significantly reducing total cost of ownership.
Funding: $66.8M
Rough estimate of the amount of funding raised
Funding: $66.8M
Rough estimate of the amount of funding raised
FocalPoint has developed Supercorrelation™ technology, a receiver-level software that enhances the accuracy and reliability of standard GNSS receivers by improving sensitivity and rejecting spoofing and jamming signals. This solution addresses the challenges of multipath interference in urban environments, providing up to 12 times greater positioning accuracy for smartphones, wearables, and autonomous vehicles.
Funding: $43.1M
Rough estimate of the amount of funding raised
Funding: $43.1M
Rough estimate of the amount of funding raised
Infinitopes develops a precision immunomics platform that identifies highly-expressed tumor antigens and employs advanced vector delivery systems to enhance T cell immunity against cancer. By initiating vaccine treatment at early stages of the patient's journey, the company aims to improve patient outcomes and reduce the risk of metastases.
Funding: $27.5M
Rough estimate of the amount of funding raised
Funding: $27.5M
Rough estimate of the amount of funding raised
The startup provides a patient-centric platform that utilizes real-time monitoring and data analytics to create personalized treatment plans for individuals with kidney disease. This platform enhances patient adherence and enables timely medical interventions, leading to improved health outcomes for those affected by kidney conditions.
Funding: $10.0M
Rough estimate of the amount of funding raised
Funding: $10.0M
Rough estimate of the amount of funding raised
NoBACZ Healthcare provides antibiotic‑free gel and liquid formulations that form an instant, waterproof barrier on wounds of cattle, sheep, and horses. The biodegradable, food‑grade resin and metal‑salt blend blocks microbes and repels water without chemicals, offering a safe, easy‑to‑apply solution for farm environments while reducing reliance on topical antibiotics.
Funding: $6.4M
Rough estimate of the amount of funding raised
Funding: $6.4M
Rough estimate of the amount of funding raised
Nu Quantum is developing the Entanglement Fabric, a networking architecture that integrates Quantum Processing Units through a Qubit-Photon Interface to create scalable, entangled qubit networks. This technology enables datacentre-scale quantum computing by facilitating modular hardware and software scaling, addressing the need for significantly more powerful quantum compute systems.
Funding: $19.9M
Rough estimate of the amount of funding raised
Funding: $19.9M
Rough estimate of the amount of funding raised
OctaiPipe provides a Federated Learning Operations (FL-Ops) framework that enables on-device AI deployment for Edge AIoT devices, minimizing data transfer to the cloud and enhancing privacy and security. This technology addresses the need for real-time decision-making and efficient management of critical infrastructure by ensuring localized intelligence and reducing vulnerability to cyber threats.
Funding: $7.7M
Rough estimate of the amount of funding raised
Funding: $7.7M
Rough estimate of the amount of funding raised
Paragraf manufactures graphene-based electronic devices, including Graphene Field-Effect Transistors and Hall Sensors, using contamination-free direct deposition technology. These devices enhance molecule sensing accuracy and sensitivity in various applications, such as healthcare and cryogenics, while improving safety in electric vehicles through advanced magnetic field detection.
Funding: $114.1M
Rough estimate of the amount of funding raised
Funding: $114.1M
Rough estimate of the amount of funding raised
Pencil Biosciences is developing a fully synthetic, modular gene editing technology that operates independently of CRISPR, enabling precise modulation of genetic sequences. This technology aims to provide new therapeutic options for patients with rare diseases by addressing the limitations of existing gene editing methods.
Funding: $10.3M
Rough estimate of the amount of funding raised
Funding: $10.3M
Rough estimate of the amount of funding raised
PharmEnable utilizes AI-driven methodologies to identify novel chemical starting points for small molecule therapeutics, specifically targeting challenging conditions in cancer and neurological diseases. This approach enhances the specificity of drug design, enabling the discovery of effective treatments for previously inaccessible biological targets.
20+
2K+Approximate amount of employees
Funding: $7.5M
Rough estimate of the amount of funding raised
Funding: $7.5M
Rough estimate of the amount of funding raised
Porotech develops Gallium Nitride-based MicroLED technology that enables the production of high-quality microLED displays for various applications, including augmented reality and automotive lighting. This technology addresses the limitations of conventional LED displays by providing enhanced brightness, efficiency, and scalability for diverse devices.
Funding: $20.0M
Rough estimate of the amount of funding raised
Funding: $20.0M
Rough estimate of the amount of funding raised
PsyOmics offers Censeo, an AI-informed platform that streamlines mental health assessments by capturing relevant patient information through a dynamic questionnaire, enhancing triage efficiency. This solution addresses the challenges of long waiting lists and misallocated resources in mental health services, enabling faster and more accurate patient care.
Funding: $15.0M
Rough estimate of the amount of funding raised
Funding: $15.0M
Rough estimate of the amount of funding raised
Qkine develops and manufactures high-quality, animal-free growth factor proteins specifically for stem cell, organoid, and cellular agriculture applications, ensuring consistent bioactivity through rigorous quality control. Their products address the need for reproducible and reliable biological materials in research and industry, enhancing scientific outcomes across various fields.
Funding: $8.0M
Rough estimate of the amount of funding raised
Funding: $8.0M
Rough estimate of the amount of funding raised
Radiant Matter develops biodegradable embellishments that create shimmering, metallic effects using structural color from renewable cellulose. Their BioSequin™ offers a sustainable, non-toxic alternative to plastic sequins, reducing microplastic pollution for fashion and consumer goods.
The startup develops a computer vision analytics platform that provides modular and scalable solutions for object detection, classification, tracking, and depth estimation in both indoor and outdoor environments. This technology enables automotive and infrastructure companies to transform passive camera feeds into actionable insights, enhancing the efficiency of large-scale transport and logistics operations.
Funding: $4.4M
Rough estimate of the amount of funding raised
Funding: $4.4M
Rough estimate of the amount of funding raised
Semarion utilizes microfabrication technology to create smart materials for precise cell assaying applications, enhancing the accuracy and efficiency of biological research. This approach addresses the need for improved methodologies in cellular analysis, enabling researchers to obtain reliable data with reduced resource consumption.
Funding: $3.6M
Rough estimate of the amount of funding raised
Funding: $3.6M
Rough estimate of the amount of funding raised
Signaloid provides a cloud-based computing platform that utilizes deterministic computation on probability distributions to enhance uncertainty quantification in AI models and Monte Carlo simulations. This technology allows users to run existing C/C++ code with minimal modifications, significantly improving the speed and accuracy of risk assessments in quantitative finance and engineering applications.
Funding: $4.2M
Rough estimate of the amount of funding raised
Funding: $4.2M
Rough estimate of the amount of funding raised
Sorex Sensors manufactures high-sensitivity film bulk acoustic resonator (FBAR) mass sensors for indoor air quality monitoring, capable of detecting harmful particulates and volatile organic compounds at femtogram levels. These sensors provide real-time data on air quality, addressing the health risks associated with invisible toxins in residential and industrial environments.
Funding: $2.8M
Rough estimate of the amount of funding raised
Funding: $2.8M
Rough estimate of the amount of funding raised
Showing 12 of 16 unmatched portfolio companies